首页> 美国政府科技报告 >"Split and Splice" Approach for Highly Selective Targeting of Human NSCLC Tumors.
【24h】

"Split and Splice" Approach for Highly Selective Targeting of Human NSCLC Tumors.

机译:“拆分和拼接”高选择性靶向人NsCLC肿瘤的方法。

获取原文

摘要

The goal of the current proposal was to develop a novel "split and splice" approach for highly selective targeting and elimination of NSCLC cells. We have optimized DnaENpu intein for Stx2A-specific intracellular delivery mechanism by replacing four lysine residues in its C-terminal part with arginines and confirming that the resulted mutated intein retains its trans-splicing activity in vivo. We have confirmed that fusion of the C-terminal DnaENpu split intein does not interfere with cellular delivery of bacterial toxins; whereas the N-terminal DnaENpu intein slows down the delivery. The work is in progress to optimize properties of the N-terminal DnaENpu intein to allow for more efficient translocation of the desired toxins by removing two cysteine residues and affecting thermodynamic properties of this part of the split intein. The most significant hindrance that we have observed is low solubility of the C-terminal Stx2A split intein constructs and their inability to form a complex with Stx2B subunits. Currently we are employing several parallel strategies to optimize solubility of the above protein constructs via co-expression and refolding/solubilization strategies.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号